35 participants
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-26
- Start Date:
- 2024-09-11
- Completion:
- 2025-09-11
Conditions
- Laryngeal Cancer
- Hypopharynx Cancer
Interventions
- COMBINATION_PRODUCT
No Results Yet